Here we describe the identification and characterization of a novel mouse g
ene, PDCR, that encodes a peroxisomal Delta(2), Delta(4)-dienoyl-CoA reduct
ase, The mouse PDCR cDNA contains an 892-base pair open reading frame and i
s predicted to encode a 292-amino acid protein with a deduced molecular mas
s of 31,298 Da that terminates in a consensus type-1 peroxisomal targeting
signal. Purified recombinant PDCR protein was generated from Escherichia co
li and catalyzed the NADPH-dependent reduction of Delta(2)-trans,Delta(4)-t
rans-decadienoyl CoA with a specific activity of 20 units/mg, Enzymatic cha
racterization followed by high pressure liquid chromatography analysis of t
he products revealed that PDCR converted Delta(2)-trans, Delta(4)-trans-dec
adienoyl-CoA to a Delta(3)-enoyl-CoA but not to a Delta(2)-enoyl-CoA. Kinet
ic analyses demonstrated that PDCR is active on a broad range of Delta(2),D
elta(4)-dienoyl-CoAs. Although the observed substrate preference was to Del
ta(2)-trans,Delta(4)-trans-decadienoyl-CoA, PDCR was also active on a C-22
substrate with multiple unsaturations, a result consistent with the role of
peroxisomes in the oxidation of complex, very long chain, polyunsaturated
fatty acids. The presence of a type-1 peroxisomal targeting signal Ala-Lys-
Leu-COOH at the C terminus of PDCR suggested that this protein may be perox
isomal. We observed that tagged PDCR was efficiently transported to the per
oxisome lumen in normal human fibroblasts but not in cells derived from a Z
ellweger syndrome patient with a specific defect in peroxisomal matrix prot
ein import. We conclude that this protein resides within the peroxisome mat
rix and therefore represents the first mammalian peroxisomal Delta(2),Delta
(4)-dienoyl-CoA reductase to be characterized at the molecular level.